• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有免疫调节和 MenA 抑制活性的新型长链化合物,可抑制金黄色葡萄球菌及其生物膜。

Novel long-chain compounds with both immunomodulatory and MenA inhibitory activities against Staphylococcus aureus and its biofilm.

机构信息

Department of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68198, USA.

出版信息

Sci Rep. 2017 Jan 10;7:40077. doi: 10.1038/srep40077.

DOI:10.1038/srep40077
PMID:28071679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5223195/
Abstract

Menaquinone (MK) biosynthesis pathway is a potential target for evaluating antimicrobials in gram-positive bacteria. Here, 1,4-dihydroxy-2-naphthoate prenyltransferase (MenA) was targeted to reduce methicillin-resistant Staphylococcus aureus (MRSA) growth. MenA inhibiting, long chain-based compounds were designed, synthesized and evaluated against MRSA and menaquinone utilizing bacteria in aerobic conditions. The results showed that these bacteria were susceptible to most of the compounds. Menaquinone (MK-4) supplementation rescued MRSA growth, suggesting these compounds inhibit MK biosynthesis. 3a and 7c exhibited promising inhibitory activities with MICs ranging 1-8 μg/mL against MRSA strains. The compounds did not facilitate small colony variant formation. These compounds also inhibited the biofilm growth by MRSA at high concentration. Compounds 3a, 6b and 7c displayed a promising extracellular bactericidal activity against MRSA at concentrations equal to and four-fold less than their respective MICs. We also observed cytokines released from THP-1 macrophages treated with compounds 3a, 6b and 7c and found decreases in TNF-α and IL-6 release and increase in IL-1β. These data provide evidence that MenA inhibitors act as TNF-α and IL-6 inhibitors, raising the potential for development and application of these compounds as potential immunomodulatory agents.

摘要

甲萘醌(MK)生物合成途径是评估革兰氏阳性菌中抗菌药物的潜在靶标。在这里,我们以 1,4-二羟基-2-萘醌 prenyltransferase(MenA)为靶点,以减少耐甲氧西林金黄色葡萄球菌(MRSA)的生长。设计、合成并评估了具有抑制 MenA 作用的长链化合物,以评估其对需氧条件下 MRSA 和利用甲萘醌的细菌的作用。结果表明,这些细菌对大多数化合物敏感。甲萘醌(MK-4)的补充挽救了 MRSA 的生长,表明这些化合物抑制了 MK 的生物合成。化合物 3a 和 7c 对 MRSA 菌株的 MIC 范围为 1-8μg/ml,表现出有希望的抑制活性。这些化合物不会促进小菌落变体的形成。这些化合物还能抑制高浓度 MRSA 的生物膜生长。化合物 3a、6b 和 7c 在与各自 MIC 相等和四倍浓度下对 MRSA 显示出有希望的细胞外杀菌活性。我们还观察到用化合物 3a、6b 和 7c 处理 THP-1 巨噬细胞释放的细胞因子,并发现 TNF-α 和 IL-6 的释放减少,IL-1β 的释放增加。这些数据表明,MenA 抑制剂作为 TNF-α 和 IL-6 的抑制剂发挥作用,这为这些化合物作为潜在的免疫调节剂的开发和应用提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fcd/5223195/f65fe077df02/srep40077-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fcd/5223195/a2a6eb88b344/srep40077-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fcd/5223195/ca6cb607a6f1/srep40077-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fcd/5223195/7fa8c395ffbb/srep40077-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fcd/5223195/226429e8c352/srep40077-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fcd/5223195/b81948010ef6/srep40077-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fcd/5223195/f65fe077df02/srep40077-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fcd/5223195/a2a6eb88b344/srep40077-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fcd/5223195/ca6cb607a6f1/srep40077-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fcd/5223195/7fa8c395ffbb/srep40077-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fcd/5223195/226429e8c352/srep40077-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fcd/5223195/b81948010ef6/srep40077-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fcd/5223195/f65fe077df02/srep40077-f6.jpg

相似文献

1
Novel long-chain compounds with both immunomodulatory and MenA inhibitory activities against Staphylococcus aureus and its biofilm.具有免疫调节和 MenA 抑制活性的新型长链化合物,可抑制金黄色葡萄球菌及其生物膜。
Sci Rep. 2017 Jan 10;7:40077. doi: 10.1038/srep40077.
2
Discovery of bicyclic inhibitors against menaquinone biosynthesis.针对甲萘醌生物合成的双环抑制剂的发现。
Future Med Chem. 2016 Jan;8(1):11-6. doi: 10.4155/fmc.15.168.
3
Discovery of 1,4-dihydroxy-2-naphthoate [corrected] prenyltransferase inhibitors: new drug leads for multidrug-resistant gram-positive pathogens.1,4-二羟基-2-萘甲酸[校正后]异戊烯基转移酶抑制剂的发现:针对多重耐药革兰氏阳性病原体的新型药物先导物
J Med Chem. 2007 Aug 23;50(17):3973-5. doi: 10.1021/jm070638m. Epub 2007 Jul 21.
4
In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea.韩国流行的耐甲氧西林金黄色葡萄球菌克隆的体外生物膜形成和杀菌活性。
Diagn Microbiol Infect Dis. 2011 May;70(1):112-8. doi: 10.1016/j.diagmicrobio.2010.11.018. Epub 2011 Mar 12.
5
Synthesis and antibiotic activity of novel acylated phloroglucinol compounds against methicillin-resistant Staphylococcus aureus.新型酰化间苯三酚类化合物的合成及其对耐甲氧西林金黄色葡萄球菌的抗菌活性。
J Antibiot (Tokyo). 2019 May;72(5):253-259. doi: 10.1038/s41429-019-0153-4. Epub 2019 Feb 13.
6
In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).高接种量或生物膜包埋的万古霉素最小抑菌浓度等于 2μg/mL(VA2-MRSA)的耐甲氧西林金黄色葡萄球菌的体外抗菌药物疗效。
Int J Antimicrob Agents. 2011 Jul;38(1):46-51. doi: 10.1016/j.ijantimicag.2011.02.013. Epub 2011 May 6.
7
A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms.联合药效定量和定性模型揭示达托霉素和德拉沙星对金黄色葡萄球菌生物膜的强大活性。
Antimicrob Agents Chemother. 2013 Jun;57(6):2726-37. doi: 10.1128/AAC.00181-13. Epub 2013 Apr 9.
8
Discovery of selective menaquinone biosynthesis inhibitors against Mycobacterium tuberculosis.发现选择性甲萘醌生物合成抑制剂对抗结核分枝杆菌。
J Med Chem. 2012 Apr 26;55(8):3739-55. doi: 10.1021/jm201608g. Epub 2012 Apr 6.
9
In vitro bactericidal activity of levonadifloxacin (WCK 771) against methicillin- and quinolone-resistant Staphylococcus aureus biofilms.左氧氟沙星(WCK 771)对耐甲氧西林和喹诺酮类药物的金黄色葡萄球菌生物膜的体外杀菌活性。
J Med Microbiol. 2019 Aug;68(8):1129-1136. doi: 10.1099/jmm.0.000999. Epub 2019 Jun 26.
10
Daptomycin exerts differential immunomodulatory effects on host responses against methicillin-resistant Staphylococcus aureus biofilms.达托霉素对耐甲氧西林金黄色葡萄球菌生物膜的宿主反应具有不同的免疫调节作用。
Int J Antimicrob Agents. 2022 Oct;60(4):106666. doi: 10.1016/j.ijantimicag.2022.106666. Epub 2022 Aug 28.

引用本文的文献

1
Potential functions of the shared bacterial taxa in the citrus leaf midribs determine the symptoms of Huanglongbing.柑橘叶中脉中共享细菌类群的潜在功能决定了黄龙病的症状。
Front Plant Sci. 2023 Nov 14;14:1270929. doi: 10.3389/fpls.2023.1270929. eCollection 2023.
2
Antibiotics in the clinical pipeline as of December 2022.截至 2022 年 12 月处于临床研发管线中的抗生素。
J Antibiot (Tokyo). 2023 Aug;76(8):431-473. doi: 10.1038/s41429-023-00629-8. Epub 2023 Jun 8.
3
Allosteric inhibition of MenD by 1,4-dihydroxy naphthoic acid: a feedback inhibition mechanism of the menaquinone biosynthesis pathway.

本文引用的文献

1
A Methyl 4-Oxo-4-phenylbut-2-enoate with Activity against MRSA that Inhibits MenB in the Bacterial Menaquinone Biosynthesis Pathway.一种对耐甲氧西林金黄色葡萄球菌有活性的4-氧代-4-苯基丁酸甲酯,它在细菌甲萘醌生物合成途径中抑制脑膜炎奈瑟菌B群(MenB)。
ACS Infect Dis. 2016 May 13;2(5):329-340. doi: 10.1021/acsinfecdis.6b00023. Epub 2016 Mar 7.
2
Development of potential broad spectrum antimicrobials using C2-symmetric 9-fluorenone alkyl amine.利用C2对称的9-芴酮烷基胺开发潜在的广谱抗菌剂。
Bioorg Med Chem Lett. 2016 Apr 15;26(8):1997-9. doi: 10.1016/j.bmcl.2016.02.087. Epub 2016 Mar 2.
3
Discovery of bicyclic inhibitors against menaquinone biosynthesis.
1,4-二羟基萘甲酸对 MenD 的变构抑制:甲萘醌生物合成途径的反馈抑制机制。
Philos Trans R Soc Lond B Biol Sci. 2023 Feb 27;378(1871):20220035. doi: 10.1098/rstb.2022.0035. Epub 2023 Jan 11.
4
Structure and activity of the DHNA Coenzyme-A Thioesterase from Staphylococcus aureus providing insights for innovative drug development.金黄色葡萄球菌 DHNA 辅酶 A 硫酯酶的结构与活性为创新药物研发提供了新的思路。
Sci Rep. 2022 Mar 12;12(1):4313. doi: 10.1038/s41598-022-08281-2.
5
New Insight into Vitamins E and K as Anti-Quorum-Sensing Agents against Pseudomonas aeruginosa.新型维生素 E 和 K 作为抗铜绿假单胞菌群体感应剂的研究进展
Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.01342-20.
6
Novel MenA Inhibitors Are Bactericidal against and Synergize with Electron Transport Chain Inhibitors.新型 MenA 抑制剂对具有杀菌作用,并与电子传递链抑制剂具有协同作用。
Antimicrob Agents Chemother. 2019 May 24;63(6). doi: 10.1128/AAC.02661-18. Print 2019 Jun.
7
Iron/Heme Metabolism-Targeted Gallium(III) Nanoparticles Are Active against Extracellular and Intracellular and .铁/血红素代谢靶向镓(III)纳米颗粒对 和 具有活性。
Antimicrob Agents Chemother. 2019 Mar 27;63(4). doi: 10.1128/AAC.02643-18. Print 2019 Apr.
8
Novel Miniature Membrane Active Lipopeptidomimetics against Planktonic and Biofilm Embedded Methicillin-Resistant Staphylococcus aureus.新型微型膜活性脂肽模拟物抗浮游和生物膜嵌入耐甲氧西林金黄色葡萄球菌。
Sci Rep. 2018 Jan 18;8(1):1021. doi: 10.1038/s41598-017-17234-z.
9
Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway.通过类黄酮实现神经保护:增强糖氧还蛋白途径。
Redox Biol. 2018 Apr;14:465-473. doi: 10.1016/j.redox.2017.10.015. Epub 2017 Oct 18.
10
Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages.镓纳米颗粒促进吞噬体成熟并抑制巨噬细胞中有毒力结核分枝杆菌的生长。
PLoS One. 2017 May 18;12(5):e0177987. doi: 10.1371/journal.pone.0177987. eCollection 2017.
针对甲萘醌生物合成的双环抑制剂的发现。
Future Med Chem. 2016 Jan;8(1):11-6. doi: 10.4155/fmc.15.168.
4
Mechanism of MenE inhibition by acyl-adenylate analogues and discovery of novel antibacterial agents.酰基腺苷酸类似物抑制MenE的机制及新型抗菌剂的发现
Biochemistry. 2015 Oct 27;54(42):6514-6524. doi: 10.1021/acs.biochem.5b00966. Epub 2015 Oct 15.
5
Prolonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages.长效多靶点镓纳米颗粒可有效抑制合并感染的人类巨噬细胞中HIV和分枝杆菌的生长。
Sci Rep. 2015 Mar 6;5:8824. doi: 10.1038/srep08824.
6
Staphylococcus aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent infections.金黄色葡萄球菌小菌落变异株(SCVs):持续性感染所涉及代谢途径的路线图
Front Cell Infect Microbiol. 2014 Jul 28;4:99. doi: 10.3389/fcimb.2014.00099. eCollection 2014.
7
Molecular modeling and docking studies of O-succinylbenzoate synthase of M. tuberculosis--a potential target for antituberculosis drug design.结核分枝杆菌O-琥珀酰苯甲酸合酶的分子建模与对接研究——抗结核药物设计的潜在靶点
Appl Biochem Biotechnol. 2014 Feb;172(3):1407-32. doi: 10.1007/s12010-013-0569-4. Epub 2013 Nov 9.
8
Cytotoxicity and modes of action of four naturally occuring benzophenones: 2,2',5,6'-tetrahydroxybenzophenone, guttiferone E, isogarcinol and isoxanthochymol.四种天然苯并二酮类化合物(2,2',5,6'-四羟基二苯甲酮、乌药素 E、异戈米醇和异银杏黄素)的细胞毒性及作用机制。
Phytomedicine. 2013 Apr 15;20(6):528-36. doi: 10.1016/j.phymed.2013.02.003. Epub 2013 Mar 16.
9
Contribution of the Staphylococcus aureus Atl AM and GL murein hydrolase activities in cell division, autolysis, and biofilm formation.金黄色葡萄球菌 Atl AM 和 GL 肽聚糖水解酶活性在细胞分裂、自溶和生物膜形成中的作用。
PLoS One. 2012;7(7):e42244. doi: 10.1371/journal.pone.0042244. Epub 2012 Jul 31.
10
Discovery of selective menaquinone biosynthesis inhibitors against Mycobacterium tuberculosis.发现选择性甲萘醌生物合成抑制剂对抗结核分枝杆菌。
J Med Chem. 2012 Apr 26;55(8):3739-55. doi: 10.1021/jm201608g. Epub 2012 Apr 6.